Hamed Shahbazi keeps the ball rolling at Well Health Technologies

It’s safe to say that Well Health Techonologies (Well Health Techonologies Stock Quote, Chart TSXV:WELL) had a busy 2018 but there’s a lot more where that came from, according to CEO Hamed Shahbazi, who says he’s excited about his company’s scaling up.

Well Health, which is in the business of consolidating and modernizing health clinics across Canada, was a presenter at this year’s Cantech Investment Conference, held over two days this past week in Toronto.

The company is coming off a recent win in acquiring NerdEMR, the largest provider of OSCAR EMR (electronic medical records) services in the province of BC. That news came on top of the continuing growth of its stable of clinics and last year’s big investment from Hong Kong business magnate Li Ka-shing, all of which makes for exciting times for WELL, says Shahbazi, a known force in Canadian tech — in 2017 Shahbazi sold Tio Networks to PayPal for $304 million before taking up the reins at Well Health last May.

“We’re very excited,” says Shahbazi. “We’re out to acquire scale and really encourage synergy between the clinical and digital arms of our business. We think that this is a very strong asset class.”

“We want to be known as the WeWork for doctors because there’s an intense competition for physicians and whoever provides them with the best experience with the best journey is going to do really well in this space,” he says. “Over the past 12 months, our clinics have processed over 600,000 patient visits, so assuming that they’ll do the same over the next 12 months, we’re talking about a just shy of $30 million revenue business and that’s without additional enhancements or organic growth. And we have positive EBITDA across all of our clinics.”

Well Health released its interim fourth quarter 2018 results on December 21, featuring revenue from continuing operations of $1,911,625 and an Adjusted EBITDA loss from continuing operations of $537,219.

Disclosure: Cantech Letter’s Nick Waddell owns shares of WELL Health

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: well
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

9 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

11 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

12 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

13 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

3 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

4 days ago